ADCT (STOCKS)
ADC Therapeutics SA
$3.910000
+0.010000 (+0.26%)
Prev close: $3.900000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Ameet Mallik
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $485.23M
- Employees
- 263
- P/E (TTM)
- -2.69
- P/B (TTM)
- -1.84
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $75.21M |
| Benefits Costs and Expenses | $241.05M |
| Costs And Expenses | $211.23M |
| Nonoperating Income/Loss | -$29.83M |
| Operating Expenses | $205.28M |
| Research and Development | $112.92M |
| Other Operating Expenses | $92.35M |
| Operating Income/Loss | -$136.02M |
| Income/Loss Before Equity Method Investments | -$165.84M |
| Income/Loss From Continuing Operations After Tax | -$166.94M |
| Income/Loss From Continuing Operations Before Tax | -$165.84M |
| Income/Loss From Equity Method Investments | $0.00 |
| Income Tax Expense/Benefit | $1.10M |
| Net Income/Loss | -$166.94M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$166.94M |
| Net Income/Loss Available To Common Stockholders, Basic | -$166.94M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.41 |
| Diluted Earnings Per Share | -$1.41 |
| Basic Average Shares | 122,003,488 |
| Diluted Average Shares | 122,003,488 |
| Assets | $289.76M |
| Current Assets | $287.15M |
| Inventory | $18.04M |
| Other Current Assets | $269.11M |
| Noncurrent Assets | $2.61M |
| Fixed Assets | $0.00 |
| Liabilities | $527.94M |
| Current Liabilities | $62.04M |
| Accounts Payable | $8.12M |
| Other Current Liabilities | $53.93M |
| Noncurrent Liabilities | $465.90M |
| Equity | -$238.18M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$238.18M |
| Liabilities And Equity | $289.76M |
| Net Cash Flow From Operating Activities | -$131.90M |
| Net Cash Flow From Operating Activities, Continuing | -$131.90M |
| Net Cash Flow From Investing Activities | -$354.00K |
| Net Cash Flow From Investing Activities, Continuing | -$354.00K |
| Net Cash Flow From Financing Activities | $92.74M |
| Net Cash Flow From Financing Activities, Continuing | $92.74M |
| Exchange Gains/Losses | -$13.00K |
| Net Cash Flow | -$39.53M |
| Net Cash Flow, Continuing | -$39.52M |
| Comprehensive Income/Loss | -$167.85M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$167.85M |
| Other Comprehensive Income/Loss | -$167.85M |
| Other Comprehensive Income/Loss Attributable To Parent | -$909.00K |